The CEO of Anagenex believes that the company's AI engine trained on billions of data points and iterative testing will blow other AI drug discovery startups out of the water.
Medtronic developed a way to reduce false alerts through its AccuRhythm™ AI algorithms. The algorithm is applied through cloud-based updates to all LINQ II™ Insertable Cardiac Monitors (ICMs) and helps improve the accuracy of information physicians receive so they can better diagnose and treat abnormal heart rhythms.
To learn more about AccuRhythm AIPlatform, please click here to download an infographic explaining how it works.
Don't miss out on this valuable opportunity to meet and discuss the latest trends and opportunities. Don't miss your chance to save with the Super Early Bird Rate.
The MedCity INVEST PhrmaTech virtual conference, scheduled for Tuesday, July 26, offers free registration and a compelling day of conversations exploring the convergence of the health tech and biopharma sectors.
The length of stay for adult inpatients is expected to rise by 8% over the next decade, driven by an increase in chronic conditions, according to a report released Tuesday by Vizient. The rise in acuity will exacerbate hospitals' capacity constraints, so they may need to rethink their care delivery models and make investments in at-home care.
Breast cancer drugs and cell therapies were prominent in this year's annual meeting of the American Society of Clinical Oncology. Here's a recap of some of the news highlights from the biggest cancer conference of the year.
"Unwinding," which refers to the process by which states will resume annual Medicaid eligibility reviews after the public health emergency ends, could begin as soon as Aug. 1, so it's important that providers develop plans now to assist patients who may be affected.
The $100 million investment will sponsor 10,000 clinicians from underrepresented racial groups who are pursuing or advancing careers in healthcare. It is the single largest philanthropic commitment ever made by the United Health Foundation.
Clinical drug testing gives physicians the ability to uncover potentially problematic drug use and preempt devastating outcomes. Physicians value these tests, but they also want clearer guidelines to optimize their use.
By Medable and MedCity News Wednesday, June 8, 2022 11:50 AM
Join us tomorrow for a webinar sponsored by Medable as we explore challenges of drug innovation in the cardiometabolic space and how connected devices could make evidence collection less costly and more efficient to support regulatory evaluation and approvals.
Armed with fresh capital, Nava Benefits hopes to take advantage of what it believes will be a disruption in the way smaller businesses approach health and wellness benefits, including the many digital tools now on the market.
RPM as we know it today – with all its advantages – falls short. The reason? Monitoring and alerting alone cannot provide one of the most critical parts of healthcare: care itself.
-Recovered.png?width=1200&height=400&upscale=true&name=DIgital%20Health%20Header(1)-Recovered.png)
No comments